Seeking Alpha

ChrisGriffith

ChrisGriffith
Send Message
View as an RSS Feed
View ChrisGriffith's Comments BY TICKER:
Latest  |  Highest rated
  • ProShares declares 1-for-4 reverse split on 16 ETFs [View news story]
    difficult math there...
    Jan 16 11:33 PM | 3 Likes Like |Link to Comment
  • Shares Of Techprecision Are Poised To Triple [View article]
    I'll take that as a no
    Jan 16 11:46 AM | 1 Like Like |Link to Comment
  • Shares Of Techprecision Are Poised To Triple [View article]
    Mark,
    Still feel good about TPCS despite the downward trend recently? Thanks
    Jan 16 11:23 AM | Likes Like |Link to Comment
  • Stock Picks For 2014 [View article]
    Yeah XIV is one that I play sporadically but will be ready to mortgage the house and get into when another crisis happens. I originally got in at $4.50 but sold around $10 and have traded in and out since then. wish i had just bought and held...
    Jan 9 05:31 PM | Likes Like |Link to Comment
  • Stock Picks For 2014 [View article]
    Can you explain the drawdowns and what would cause them? Thanks!
    Jan 8 09:30 AM | Likes Like |Link to Comment
  • Best Ideas For 2014: Long GCVRZ [View article]
    I was thinking the same thing Clayton. Although the article made a compelling argument for a reason to buy ahead of the FDA decision, a "best pick for 2014" should technically start tomorrow. I sympathize with those that bought prior to the 65% drop, but such is the case of playing with stocks prior to an FDA approval. Blaming Chris that one part of his overall thesis didn't play out, and 52 weeks prior to actually realizing the performance of his 2014 pick, is very off base in my opinion.

    I have made multiple trading decisions that have cost me plenty, but the best thing to do is learn from it and re-evaluate the position (not blame others that you made it in the first place). As far as I know, Chris didn't force anyone to make the purchase or bought it on their behalf. I think if you believed in the overall thesis before it dropped, now is an even more compelling valuation and I entered a position after the drop.

    Hopefully Chris will give us his update soon. Good luck to everyone and Happy New Year
    Jan 1 11:34 AM | 5 Likes Like |Link to Comment
  • Notable earnings before Monday‚Äôs open [View news story]
    CALM before the storm?
    Dec 29 05:37 PM | 1 Like Like |Link to Comment
  • VIX Contango Comet - Profitable Observations [View article]
    Where did the new site get moved to? I haven't been on in a while. Thanks!
    Dec 26 01:11 PM | Likes Like |Link to Comment
  • Yes Mrs. Yellen, QE Is Creating An Asset Bubble [View article]
    I'm with Michael on this one. Even if we are in a bubble (which I believe we are), there is no specific time frame for the bubble to pop and if it takes longer than several weeks or months, you will have taken substantial losses on your UVXY position and will be hoping to break even at that point. Terrible suggestion for other investors who follow your articles.
    Nov 18 06:32 PM | 1 Like Like |Link to Comment
  • How Do You Fake 7 Of 16 Five-Year Glioblastoma Survivors? [View article]
    Agreed. Redacre I could care less if you're long or short but don't say you're long and then provide only bearish analysis in your comments. I highly doubt an investor that is Long in $IMUC would be talking about management misleading investors. Own up to your real position
    Nov 13 05:44 PM | 6 Likes Like |Link to Comment
  • ImmunoCellular Stagnates With Trial Read-Out Still Months Away [View article]
    I wouldn't call 3.5% for a small-cap biotech stock "clobbered". ARIA today is what I'd consider clobbered
    Oct 9 11:15 AM | Likes Like |Link to Comment
  • Gee, Texas? Aye! [View instapost]
    Joe,
    Big day for GTXI today. Do you still see this one as attractive or is it time to sell after the nice run-up?
    Sep 19 05:44 PM | Likes Like |Link to Comment
  • ImmunoCellular Stagnates With Trial Read-Out Still Months Away [View article]
    P Man, if the success of the whole trial is predicated on extending the life above the standard of care, the longer it takes for the 64th event, the better the odds that it will be considered successful.

    Your statement makes no sense. If it takes until mid-2014 to get to the 64th event, obviously the treatment is working much better than current drugs on the market.
    Aug 13 11:03 PM | 2 Likes Like |Link to Comment
  • 6 Reasons ImmunoCellular Therapeutics Is One Of The Best Risk Vs. Rewards In The Market [View article]
    Vdineshk, just tried that and didn't get any results...
    Aug 8 08:49 AM | Likes Like |Link to Comment
  • 6 Reasons ImmunoCellular Therapeutics Is One Of The Best Risk Vs. Rewards In The Market [View article]
    Correct me if I'm wrong but at first glance their "earnings" look pretty good. $0.00 per share vs expectations of $0.08/share, less cash burn than last year, etc.

    Is that how you'd interpret it?
    Aug 7 04:08 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
100 Comments
117 Likes